Prevention of respiratory syncytial virus infections

被引：0
|
作者：
Coudert, Pascal [1 ]
机构：
[1] Univ Clermont Auvergne, Fac Pharm, Lab Chim Therapeut, 28 pl Henri Dunant, F-63001 Clermont Ferrand 1, France
来源：
ACTUALITES PHARMACEUTIQUES | 2024年 / 63卷 / 639期
关键词：
bronchiolitis; glycoprotein; nirevimab; palivizumab; respiratory syncytial virus; vaccination;
D O I：
10.1016/j.actpha.2024.07.008
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The respiratory syncytial virus is responsible for potentially serious infections of the upper and lower airways at all ages. Simple, effective hygiene practices limit transmission of the virus that causes bronchiolitis, among other diseases. The availability and development of new preventive treatments based on monoclonal anti bodies or vaccination will ensure the protection of all fragile populations.
引用
收藏
页码：30 / 32
页数：3
相关论文
共 50 条
  • [31] Respiratory syncytial virus disease: update on treatment and prevention
    Krilov, Leonard R.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (01) : 27 - 32
  • [32] Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions
    Binns, Elly
    Tuckerman, Jane
    Licciardi, Paul, V
    Wurzel, Danielle
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2022, 58 (10) : 1741 - 1746
  • [33] Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)
    Bergeron, Harrison C.
    Tripp, Ralph A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (01) : 23 - 29
  • [34] Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
    Gatt, Dvir
    Martin, Isaac
    AlFouzan, Rawan
    Moraes, Theo J. J.
    PATHOGENS, 2023, 12 (02):
  • [35] Respiratory syncytial virus infections in infants and children with congenital heart disease: update on the evidence of prevention with palivizumab
    Resch, Bernhard
    Michel-Behnke, Ina
    CURRENT OPINION IN CARDIOLOGY, 2013, 28 (02) : 85 - 91
  • [36] Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection
    Resch, Bernhard
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (09) : 2138 - 2149
  • [37] Respiratory syncytial virus - associated lower respiratory tract infections in hospitalized infants
    D'Elia, C
    Siqueira, MM
    Portes, SA
    Sant'Anna, CC
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2005, 38 (01) : 7 - 10
  • [38] The dawn of preventing respiratory syncytial virus lower respiratory tract infections in children
    Dangor, Z.
    Madhi, S. A.
    Zar, H. J.
    Demopoulos, D.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2024, 114 (12): : 14 - 17
  • [39] Respiratory Syncytial Virus Infections in Children With Cancer
    Chemaly, Roy F.
    Ghantoji, Shashank S.
    Shah, Dimpy P.
    Shah, Jharna N.
    El Taoum, Katia K.
    Champlin, Richard E.
    Nunez, Cesar A.
    Mulanovich, Victor
    Ariza-Heredia, Ella
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (06) : E376 - E381
  • [40] Respiratory syncytial virus infections in Central Australia
    Dede, Apakasiamaka
    Isaacs, David
    Torzillo, Paul J.
    Wakerman, John
    Roseby, Rob
    Fahy, Rose
    Clothier, Tors
    White, Andrew
    Kitto, Paula
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2010, 46 (1-2) : 35 - 39
12345